Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases

Targeting survivin in cancer

(2012) Dario C. Altieri   CANCER LETTERS

Survivin Silencing as a Promising Strategy To Enhance the Sensitivity of Cancer Cells to Chemotherapeutic Agents

(2011) S. Trabulo et al.   MOLECULAR PHARMACEUTICS

IAP Regulation of Metastasis

(2010) Swarna Mehrotra et al.   CANCER CELL

Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and  5 Integrin Upregulation

(2010) J. A. McKenzie et al.   CANCER RESEARCH

Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study

(2010) D. C. Talbot et al.   CLINICAL CANCER RESEARCH

Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung

(2010) Melanie Günther et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

(2010) Jiri Vachtenheim et al.   EXPERIMENTAL DERMATOLOGY

Surgical and Nonresectional Therapies for Pulmonary Metastasis

(2010) Yifan Zheng et al.   SURGICAL CLINICS OF NORTH AMERICA

Systemic Delivery of DNA or siRNA Mediated by Linear Polyethylenimine (L-PEI) Does Not Induce an Inflammatory Response

(2008) Marie-Elise Bonnet et al.   PHARMACEUTICAL RESEARCH